| abstract |
The present invention provides a novel preventive or therapeutic agent for hearing loss diseases having an extremely excellent effect. A preventive or therapeutic agent for hearing loss diseases, comprising a methyl group donor and a histone deacetylase inhibitor. L-methionine, D-methionine, S-adenosylmethionine and the like are suitably used as the methyl group donor, and sodium valproate is preferably used as the histone deacetylase inhibitor. [Selection] Figure 1 |